|
Mean Corpuscular Volume (result)
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genetic Loci implicated in erythroid differentiation and cell cycle regulation are associated with red blood cell traits.
|
22560525 |
2012 |
|
Red Blood Cell Count measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genetic Loci implicated in erythroid differentiation and cell cycle regulation are associated with red blood cell traits.
|
22560525 |
2012 |
|
Mean corpuscular hemoglobin concentration determination
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genetic Loci implicated in erythroid differentiation and cell cycle regulation are associated with red blood cell traits.
|
22560525 |
2012 |
|
Corpuscular Hemoglobin Concentration Mean
|
|
0.700 |
GeneticVariation
|
GWASDB |
Seventy-five genetic loci influencing the human red blood cell.
|
23222517 |
2012 |
|
Finding of Mean Corpuscular Hemoglobin
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genetic Loci implicated in erythroid differentiation and cell cycle regulation are associated with red blood cell traits.
|
22560525 |
2012 |
|
Hemoglobin E disease
|
|
0.700 |
GeneticVariation
|
GWASCAT |
A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E.
|
20183929 |
2010 |
|
Red Blood Cell Count measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.
|
19862010 |
2009 |
|
Fetal hemoglobin determination
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.
|
18245381 |
2008 |
|
Chronic myeloproliferative disorder
|
|
0.020 |
GeneticVariation
|
BEFREE |
This study aimed to establish the additional contribution of the recently described MECOM rs2201862, HBS1L-MYB rs9376092 and THRB-RARB rs4858647 polymorphisms to the occurrence of MPN.
|
29047144 |
2018 |
|
Thrombocythemia, Essential
|
|
0.020 |
GeneticVariation
|
BEFREE |
HBS1L-MYB rs9376092 associated only with JAK2 V617F-mutated ET (OR = 1.4; 95% CI = 1.1-1.7; P-value = .003).
|
29047144 |
2018 |
|
Polycythemia Vera
|
|
0.020 |
GeneticVariation
|
BEFREE |
Furthermore, the risk alleles of <i>MECOM</i> rs2201862 and <i>HBS1L</i>-<i>MYB</i> rs9376092 were demonstrated to be negatively associated with the risk of developing polycythemia vera.
|
29100304 |
2017 |
|
Chronic myeloproliferative disorder
|
|
0.020 |
GeneticVariation
|
BEFREE |
Here we aimed to evaluate the association of five germline variations (<i>JAK2</i> 46/1 haplotype tagged by rs12343867, <i>JAK2</i> intron 8 rs12339666, <i>TERT</i> rs2736100, <i>HBS1L</i>-<i>MYB</i> rs9376092 and <i>MECOM</i> rs2201862) and the risk of MPNs in Taiwanese population.
|
29100304 |
2017 |
|
Thrombocythemia, Essential
|
|
0.020 |
GeneticVariation
|
BEFREE |
Reduced MYB expression, previously linked to development of an ET-like disease in model systems, associates with rs9376092 in normal myeloid cells.
|
25849990 |
2015 |
|
Polycythemia Vera
|
|
0.020 |
GeneticVariation
|
BEFREE |
Two additional SNPs, rs2736100 (TERT) and rs9376092 (HBS1L/MYB), achieve genome-wide significance when including JAK2(V617F)-positive cases. rs9376092 has a stronger effect in JAK2(V617F)-negative cases with CALR and/or MPL mutations (Breslow-Day P=4.5 × 10(-7)), whereas in JAK2(V617F)-positive cases rs9376092 associates with essential thrombocythemia (ET) rather than polycythemia vera (allelic χ(2) P=7.3 × 10(-7)).
|
25849990 |
2015 |